Shelter Pharma Limited is trading higher at RS 42.70, up by 1.86 points or 4.55% from its previous close of RS 40.84 on the BSE.

The stock opened at RS 42.50 and recorded an intraday high and low of RS 44.29 and RS 42.50 respectively, with around 27,000 shares traded so far.

Belonging to the BSE ‘M’ group, the company’s stock with a face value of RS 10 has marked a 52-week high of RS 69.70 (on January 8, 2025) and a 52-week low of RS 35.70 (on March 27, 2025). Over the last week, the scrip has traded between RS 44.29 and RS 40.40. Shelter Pharma’s current market capitalization stands at RS 63.46 crore.

The company’s promoters hold 52.32%, while non-institutional investors own 47.68% of the equity.

In a recent development, Shelter Pharma received a major order from Taha Drugs & Chemicals Co. for its Joemega Capsules and Vitamin Tablets, valued at USD 98,875. The order is expected to be completed within two months.

Shelter Pharma specializes in the manufacturing of herbal pharmaceutical products, catering to both human and veterinary segments with a strong market presence.